M&A Deal Summary

Curia Acquires Hyaluron

On June 14, 2010, Curia acquired healthcare services company Hyaluron

Acquisition Highlights
  • This is Curia’s 1st transaction in the Healthcare Services sector.
  • This is Curia’s 1st transaction in the United States.
  • This is Curia’s 1st transaction in Massachusetts.

M&A Deal Summary

Date 2010-06-14
Target Hyaluron
Sector Healthcare Services
Buyer(s) Curia
Deal Type Add-on Acquisition

Target

Hyaluron

Burlington, Massachusetts, United States
Hyaluron provides these services for both small molecule drug products as well as biologicals, from clinical phase to commercial scale.

Search 215,130 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Curia

Albany, New York, United States

Category Company
Founded 1991
Sector Life Science
Employees2,220
Revenue 402M USD (2015)
DESCRIPTION

Curia is a contract development and manufacturing organization (CDMO) providing services from drug discovery through development and manufacturing for small molecules, generic APIs, and biologics. The company draws on many years of experience and operates globally with integrated facilities in North America, Europe, and Asia. Curia was founded in 1991 and is headquartered in Albany, New York.


DEAL STATS #
Overall 2 of 11
Sector: Healthcare Services M&A 1 of 1
Type: Add-on Acquisition M&A Deals 2 of 8
State: Massachusetts M&A 1 of 1
Country: United States M&A 1 of 7
Year: 2010 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-02-17 Excelsyn

Flintshire, United Kingdom

Excelsyn is a pharmaceutical services company, providing a broad range of cost-effective process chemistry solutions from lab to plant scale to the pharmaceutical industry. Excelsyn works with biotech, pharmaceutical and fine chemical companies worldwide helping customers progress compounds across pre-clinical, clinical and commercial phases by providing small molecule synthesis, scale-up solutions and support services.

Buy $19M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-04-04 Cedarburg Pharmaceuticals

Grafton, Wisconsin, United States

Cedarburg Pharmaceuticals, Inc. is a contract development and manufacture of active pharmaceutical ingredients and pharmaceutical intermediates.

Buy $41M